Rosalind Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-282
Closed -$19.6K 38
2024
Q2
$19.6K Hold
282
0.02% 35
2024
Q1
$168K Hold
282
0.16% 31
2023
Q4
$363K Buy
+282
New +$363K 0.3% 27